Golden Ally Lifetech Group, Inc. (AQPW) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.25: the stock has moved about 25% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGolden Ally Lifetech Group, Inc. (AQPW) trades at $0.0001. Golden Ally Lifetech Group, Inc. is a development stage company focused on advanced technologies, energy solutions, and medical devices. Sector: Consumer staples.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for AQPW: AQPW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Golden Ally Lifetech Group, Inc. (AQPW) Consumer Business Overview
Golden Ally Lifetech Group, Inc., operating in the consumer defensive sector, is in the development stage, concentrating on bioscience, sport medicines, energy solutions, and graphene applications. Its diverse product pipeline, including self-sanitizing devices and energy solutions, positions it within the non-alcoholic beverages industry, albeit with a broader technology focus.
What Is the Investment Thesis for AQPW?
Golden Ally Lifetech Group, Inc. presents a speculative investment opportunity given its development stage status and focus on emerging technologies. Key value drivers include successful commercialization of its Sterilal self-sanitizing devices, PASS smart denture mouth guards, and InCharge energy solutions. The company's ability to secure partnerships and funding for its graphene de-icing application could also drive growth. However, the company's limited operating history, OTC market listing, and lack of revenue generation pose significant risks. Investors should carefully consider the high level of uncertainty and potential for dilution before investing. The company's beta of 1.25 indicates higher volatility compared to the market.
Based on FMP financials and quantitative analysis
AQPW Key Highlights
Golden Ally Lifetech Group, Inc. is a development stage company focused on bioscience, sport medicines, energy solutions, and graphene applications.
- The company's product pipeline includes Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems.
- Golden Ally Lifetech is developing the InCharge magnetic-based battery device for energy solutions.
- The company is exploring the application of graphene for de-icing in the airline industry.
- Golden Ally Lifetech Group, Inc. trades on the OTC market, indicating higher risk and lower liquidity.
Who Are AQPW's Competitors?
AQPW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| REED Reed's, Inc. | $0.70 | +3.60% | $8.23M | — |
| BRFH Barfresh Food Group, Inc. | $0.85 | -2.69% | $13.8M | — |
| BNKK Bonk, Inc. | $1.75 | -0.57% | $14.0M | — |
| ZVIA Zevia PBC | $1.21 | 0.00% | $86.9M | 34 5-pillar |
| BUDA Buda Juice Inc. | $7.71 | -8.21% | $96.9M | 70 5-pillar |
| SHOT Safety Shot, Inc. | $9.86 | -0.10% | $213M | 69 5-pillar |
| OTLY Oatly Group AB | $10.55 | +1.15% | $329M | — |
| FIZZ National Beverage Corp. | $30.32 | +2.12% | $2.84B | 87 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AQPW's Key Strengths?
Innovative technologies in bioscience, energy, and materials science.
- Diverse product pipeline with potential for multiple revenue streams.
- Experienced management team with expertise in technology development.
- Strategic partnerships with established companies.
What Are AQPW's Weaknesses?
Development stage company with limited operating history.
- Dependence on external funding for research and development.
- OTC market listing with limited liquidity and higher risk.
- Lack of revenue generation and profitability.
What Are the Key Risks for AQPW?
Financial-distress signal — its Altman Z-Score of -23.91 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Limited operating history and lack of revenue generation.
- Dependence on external funding for research and development.
- OTC market listing with limited liquidity and higher risk.
- Competition from established companies with greater resources.
- Regulatory hurdles and lengthy approval processes.
What Threats Does AQPW Face?
- Competition from established companies with greater resources.
- Regulatory hurdles and lengthy approval processes.
- Technological obsolescence and rapid innovation.
- Economic downturn and reduced consumer spending.
What Are AQPW's Competitive Advantages?
- Proprietary technologies in bioscience, energy, and materials science.
- Potential for patents and intellectual property protection.
- First-mover advantage in niche markets.
- Strategic partnerships with established companies.
What Does AQPW Do?
Golden Ally Lifetech Group, Inc., established in 2003 and based in Austin, Texas, is a development stage company focused on creating advanced technologies, energy solutions, and medical devices. Originally named Signet International Holdings, Inc., the company rebranded in July 2022 to reflect its evolving focus. The company's core business revolves around the development of innovative products in bioscience and sports medicine. These include Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems. Beyond medical applications, Golden Ally Lifetech is also developing the InCharge magnetic-based battery device for energy solutions. Additionally, the company explores the application of graphene for de-icing in the airline industry, showcasing its commitment to diverse technological advancements. As a development stage company, Golden Ally Lifetech is currently focused on research, development, and commercialization of its technologies.
What Products and Services Does AQPW Offer?
- Develop advanced technologies in bioscience and sport medicines.
- Create self-sanitizing devices for various applications.
- Design smart denture mouth guards for improved oral health.
- Develop handheld heart attack sensors for early detection.
- Create melanoma detection systems for skin cancer screening.
- Offer magnetic-based battery devices for energy solutions.
- Develop graphene applications for de-icing in the airline industry.
How Does AQPW Make Money?
- Develop and commercialize innovative technologies in bioscience, energy, and materials science.
- Generate revenue through the sale of products and licensing of technologies.
- Seek partnerships with established companies for distribution and commercialization.
- Explore government grants and funding opportunities to support research and development.
What Industry Does AQPW Operate In?
Golden Ally Lifetech Group, Inc. operates within the consumer defensive sector, specifically targeting the non-alcoholic beverages industry with its energy solutions and advanced technologies. The company's focus on bioscience and sport medicines places it in a niche market with potential for growth. The competitive landscape includes companies like ALKM, BLEG, DZGH, EESO, and FBEC, which are also exploring innovative solutions in the beverage and related industries. The market for advanced technologies and energy solutions is expected to grow, driven by increasing demand for sustainable and efficient products.
Who Are AQPW's Key Customers?
- Healthcare providers seeking advanced diagnostic and treatment solutions.
- Athletes and sports enthusiasts looking for performance-enhancing and protective devices.
- Consumers seeking convenient and effective energy solutions.
- Airlines seeking innovative de-icing solutions to improve efficiency and safety.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Golden Ally Lifetech Group, Inc. operates in the Beverages - Non-Alcoholic industry within the Consumer Defensive sector. It is headquartered in Austin, US. The company is led by CEO Oliver Keren Ban. AQPW has traded publicly since 2007.
Financial Health
Golden Ally Lifetech Group, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -23.91 places it in the distress zone, a signal of elevated financial risk.
AQPW Financials
AQPW Latest News
No recent news available for AQPW.
AQPW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AQPW.
Price Targets
Wall Street price target analysis for AQPW.
AQPW MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AQPW; grades run from A+ (80-100) to F (below 30).
Leadership: Oliver Keren Ban
CEO
Oliver Keren Ban serves as the CEO of Golden Ally Lifetech Group, Inc. His background includes experience in managing and developing technology-focused companies. He has been involved in various aspects of business development, including strategic planning, financial management, and product development. His leadership aims to drive innovation and commercialization of the company's diverse product pipeline.
Track Record: Under Oliver Keren Ban's leadership, Golden Ally Lifetech Group, Inc. has focused on developing advanced technologies in bioscience, energy solutions, and medical devices. Key milestones include the development of Sterilal self-sanitizing devices, PASS smart denture mouth guards, and InCharge magnetic-based battery device. The company has also explored the application of graphene for de-icing in the airline industry.
AQPW OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Golden Ally Lifetech Group, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may be subject to greater price volatility. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing.
- OTC Tier: OTC Other
- Limited liquidity and wider bid-ask spreads.
- Lack of regulatory oversight and potential for fraud or manipulation.
- Limited financial disclosure and transparency.
- Higher price volatility and risk of significant losses.
- Potential for dilution through stock offerings.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's intellectual property and patent portfolio.
- Review the company's legal and regulatory compliance.
- Monitor the company's trading volume and price activity.
- Consult with a qualified financial advisor.
- Company has a registered business address and contact information.
- Company has a functional website with information about its products and services.
- Company has a management team with relevant experience.
- Company has a clear business plan and strategy.
- Company has secured partnerships or funding from reputable sources.
Golden Ally Lifetech Group, Inc. Consumer Staples Stock: Key Questions Answered
What do analysts say about AQPW stock?
As of 2026-03-17, there is no readily available analyst coverage specifically for Golden Ally Lifetech Group, Inc. (AQPW). Given its OTC listing and development stage status, the stock is likely not widely followed by major brokerage firms.
What are the main risks for AQPW?
Investing in Golden Ally Lifetech Group, Inc. carries significant risks due to its development stage status, OTC market listing, and limited financial disclosure. The illiquidity of OTC stocks can make it difficult to buy or sell shares at desired prices.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on limited data available for this OTC-listed company.